GLP-1 Weight-Loss Medication in the UAE: How It Is Prescribed and What It Involves

GLP-1 receptor agonists are prescription medicines that imitate a gut hormone the body releases after eating. They slow the rate at which the stomach empties and act on the parts of the brain that register fullness, so appetite and food intake tend to fall. Tirzepatide works on two hormone receptors rather than one. All of them are given as a subcutaneous injection from a pre-filled pen, usually once a week, starting at a low dose that is raised in steps. They are medicines, not supplements or cosmetic injectables. In the UAE they are prescription-only, dispensed by a licensed pharmacy against a prescription written by a licensed doctor. They are intended as one part of a supervised plan alongside changes to diet and activity, and they are not a substitute for that plan. The brands differ. Some are licensed for type 2 diabetes and some for weight management, and the licensed indication can differ between markets; using a medicine outside its licensed indication is described as off-label, and it is a decision the prescribing doctor makes and records with you. Outcomes, tolerance and side effects vary between individuals, and this page does not state an expected result. It is general information and does not replace a consultation.

These medicines are prescription-only in the UAE. The lawful pathway has three steps, and each one exists for a reason. First, a consultation with a licensed doctor: DHA, DHCC, DOH or MOHAP licensed, depending on the emirate. Second, a medical assessment before anything is prescribed: your history and current medicines, height, weight and measurements, an examination, blood tests where indicated, and a screen for the conditions that make these medicines unsuitable. Third, dispensing by a licensed pharmacy against that prescription, where a pharmacist checks the product, the dose and your other medicines. After that, supervision continues. A legitimate programme reviews you as the dose is raised, checks how you are tolerating it, and has a plan for what happens if side effects appear, if the dose needs to change, or if you stop. What this pathway is not: it is not a form filled in on a website with no examination, it is not a pen bought from a social-media seller or an unlicensed online shop, and it is not a supply carried back from a pharmacy abroad. Those routes remove the pharmacist check, the cold chain and any record that ties the medicine to you. If a source will supply without a prescription, that in itself tells you it is outside the licensed chain.

Cost on this topic has two layers, and they behave differently. The first layer is the medicine. Published pharmacy list prices give a clear reference for the named pack and strength, while the pharmacy’s current checkout price can reflect a promotion. Confirm the exact product, pack and strength before paying. The second layer is the clinical programme around the medicine: the consultation, the assessment and blood tests, the dose reviews, the follow-up and any dietetic support. That is a professional service, the clinic sets its price, and it genuinely does differ between providers. This is the layer where asking what is included changes what you pay. Because of that split, figures published by clinics for this topic are not like-for-like, and MediFinder does not present them as a single comparable range. Some repeat a pharmacy price, some cover a supervised programme, some are a first-month or lowest-dose starting figure, and some bundle the medicine and the service together. Before setting two figures against each other, establish which layer each one describes, what it includes, and what it becomes at a maintenance dose over several months.

Before agreeing to a programme, get the following in writing. The aim is to know what you are buying, over what period, and what happens when the dose changes.

• Whether the figure is for the medicine, the clinical service, or both
• The initial consultation and medical assessment
• Baseline blood tests, and whether repeat tests are charged separately
• How many follow-up reviews are included, and over what period
• What happens to the figure when the dose is increased
• Whether dietetic or nutrition support is part of the service
• Where the medicine is dispensed, and that the pharmacy is licensed
• Whether VAT and any other charges are included

A proper assessment exists to find the reasons not to prescribe. It should cover, at minimum: a personal or family history of medullary thyroid carcinoma, or of the inherited condition MEN 2 (multiple endocrine neoplasia type 2); a history of pancreatitis; pregnancy, breastfeeding, or planning a pregnancy; gallbladder disease; severe gastrointestinal disease including gastroparesis; type 1 diabetes; a history of an eating disorder; kidney or liver disease; and every other medicine you take, including insulin or other diabetes medicines, because doses may need adjusting. Side effects are common rather than rare, and are mostly gastrointestinal: nausea, vomiting, diarrhoea, constipation, reflux and abdominal discomfort, typically worst in the days after a dose increase. Less common but more serious problems include pancreatitis, gallbladder problems, dehydration and, in people taking certain diabetes medicines, low blood sugar. Severe or persistent abdominal pain, repeated vomiting, or signs of dehydration are reasons to contact a doctor rather than to wait. Supervision matters for reasons beyond the prescription. Rapid weight change alters nutritional needs and can affect muscle mass, so protein intake and activity should be part of the plan. If you stop, appetite usually returns and weight often follows, which is a conversation to have before starting rather than after. Anyone with a history of disordered eating needs that assessed first. Responses differ between individuals, and nobody can tell you in advance how you will respond or how well you will tolerate it. This page is general information and is not medical advice; it does not replace an assessment by a licensed doctor who knows your history.

Demand for these medicines has outrun supply in many countries, and falsified pens have followed. The World Health Organization issued a medical product alert in June 2024 about falsified semaglutide pens identified in several regions, and national regulators including the US FDA have warned about counterfeit product reaching patients. Seized product has been found to contain the wrong substance, no active substance at all, insulin, bacterial contamination, or unapproved experimental compounds. Documented harm includes both dangerously low and dangerously high blood sugar. Price alone cannot prove whether a pen is genuine. A promotion from a licensed UAE pharmacy is different from an unusually cheap offer by an unknown seller. Treat an offer well below established pharmacy listings as a reason to verify the seller, prescription route, product and pack rather than as proof of either a good deal or a counterfeit. Other checks: buy only through a licensed UAE pharmacy against your own prescription, and keep the receipt. Look at the pack: misspellings, a label that peels or looks reprinted, a batch number or expiry that does not match between the carton and the pen, a missing or damaged tamper seal, or a needle that does not fit are all reasons to stop. Look at the pen: an unexpected colour, a dose dial that turns differently from the one you were shown, or a solution that is cloudy or has particles in it. Be wary of a seller who has stock when pharmacies do not, who asks for payment by transfer to a personal account, or who ships without a prescription. If you suspect a pen is falsified, do not inject it. Keep it and the packaging, contact the pharmacy or clinic that supplied it, and report it to the Emirates Drug Establishment or your local health authority. If you have already injected it and feel unwell, seek medical help and take the pen with you.

The regulatory and clinical facts this page rests on, in one place.

Legal status in the UAE

Prescription-only medicine

Who may prescribe

A doctor licensed by DHA, DHCC, DOH or MOHAP

Where it is dispensed

A licensed pharmacy, against a prescription

Medicine price

Mounjaro: AED 1,734; Ozempic: AED 743.50 (0.25/0.5 mg) or AED 1,146 (1 mg)

What varies between clinics

The clinical programme: assessment, tests, reviews and follow-up

How it is taken

A subcutaneous pen injection, usually weekly, with stepwise dose increases

Assessment before prescribing

History, measurements, examination, blood tests where indicated, contraindication screen

Clinical review status

General information, not clinically reviewed

Clinics offering medical weight management are listed by emirate below. Licensing authority differs by emirate, so a doctor licensed in one may not be licensed in another.

• Dubai
• Abu Dhabi

Medicines are one route. Surgical and endoscopic procedures are assessed differently, by a bariatric team, and suit different circumstances.

• Sleeve gastrectomy in the UAE
• Gastric bypass in the UAE
• Gastric balloon insertion and removal